Cargando…
In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design
A controlled release matrix formulation for mesalamine was designed and developed to achieve a 24 h release profile. Using compritol 888 ATO (glyceryl behenate) as an inert matrix-forming agent to control the release of mesalamine, formulation granules containing the solid dispersions were investiga...
Autores principales: | Patel, J.K., Patel, N.V., Shah, S.H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093632/ https://www.ncbi.nlm.nih.gov/pubmed/21589801 |
Ejemplares similares
-
Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion
por: Jagdale, SC, et al.
Publicado: (2011) -
Influence of Formulation Factors and Compression Force on Release Profile of Sustained Release Metoprolol Tablets using Compritol(®) 888ATO as Lipid Excipient
por: Patere, Shilpa N., et al.
Publicado: (2015) -
Development and Validation of Spectrophotometric Methods for the Estimation of Mesalamine in Tablet Dosage Forms
por: Patel, KM, et al.
Publicado: (2010) -
Gastric Pharmacobezoar of Mesalamine Tablets Retrieved Endoscopically
por: Sultania, Surender, et al.
Publicado: (2017) -
Compritol-Based Alprazolam Solid Lipid Nanoparticles for Sustained Release of Alprazolam: Preparation by Hot Melt Encapsulation
por: Rao, Huma, et al.
Publicado: (2022)